Lee’s Pharmaceutical Holdings Limited (referred to as “Lee’s Pharm” or “the Group”, stock code: 00950) and Shaohe Biotechnology Co., Ltd., Guangdong (hereinafter referred to as “Shaohe Biotech”) announced a strategic partnership to jointly build a new ecosystem for the probiotic industry. This collaboration aims to translate probiotic research from the laboratory to public health applications, offering precise and scientifically driven solutions for national health management.
Thai 
English